ZYLOPRIM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zyloprim, and when can generic versions of Zyloprim launch?
Zyloprim is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in ZYLOPRIM is allopurinol. There are twenty-two drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zyloprim
A generic version of ZYLOPRIM was approved as allopurinol by WATSON LABS on September 28th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZYLOPRIM?
- What are the global sales for ZYLOPRIM?
- What is Average Wholesale Price for ZYLOPRIM?
Summary for ZYLOPRIM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 274 |
| Clinical Trials: | 25 |
| Patent Applications: | 4,943 |
| Drug Prices: | Drug price information for ZYLOPRIM |
| What excipients (inactive ingredients) are in ZYLOPRIM? | ZYLOPRIM excipients list |
| DailyMed Link: | ZYLOPRIM at DailyMed |
Recent Clinical Trials for ZYLOPRIM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | Phase 1/Phase 2 |
| Instituto Nacional de Cardiologia Ignacio Chavez | Phase 3 |
| Instituto Nacional de Rehabilitacion | Phase 3 |
Pharmacology for ZYLOPRIM
| Drug Class | Xanthine Oxidase Inhibitor |
| Mechanism of Action | Xanthine Oxidase Inhibitors |
US Patents and Regulatory Information for ZYLOPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ZYLOPRIM | allopurinol | TABLET;ORAL | 016084-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Casper Pharma Llc | ZYLOPRIM | allopurinol | TABLET;ORAL | 016084-003 | Aug 4, 2022 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Casper Pharma Llc | ZYLOPRIM | allopurinol | TABLET;ORAL | 016084-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZYLOPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ZYLOPRIM | allopurinol | TABLET;ORAL | 016084-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Casper Pharma Llc | ZYLOPRIM | allopurinol | TABLET;ORAL | 016084-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
